FOXC1: an emerging marker and therapeutic target for cancer

被引:0
|
作者
B Han
N Bhowmick
Y Qu
S Chung
A E Giuliano
X Cui
机构
[1] Samuel Oschin Comprehensive Cancer Institute,Department of Surgery
[2] Cedars-Sinai Medical Center,Department of Medicine
[3] Samuel Oschin Comprehensive Cancer Institute,undefined
[4] Cedars-Sinai Medical Center,undefined
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC, as well as the implications of these new findings in cancer diagnosis and treatment.
引用
收藏
页码:3957 / 3963
页数:6
相关论文
共 50 条
  • [1] FOXC1: an emerging marker and therapeutic target for cancer
    Han, B.
    Bhowmick, N.
    Qu, Y.
    Chung, S.
    Giuliano, A. E.
    Cui, X.
    ONCOGENE, 2017, 36 (28) : 3957 - 3963
  • [2] Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
    Landon Mott
    Kai Su
    Daniel W. Pack
    Cancer Gene Therapy, 2018, 25 : 84 - 91
  • [3] Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
    Mott, Landon
    Su, Kai
    Pack, Daniel W.
    CANCER GENE THERAPY, 2018, 25 (3-4) : 84 - 91
  • [4] FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Du, Juan
    Li, Lin
    Ou, Zhouluo
    Kong, Chenfei
    Zhang, Yu
    Dong, Zhixiong
    Zhu, Shan
    Jiang, Hao
    Shao, Zhimin
    Huang, Baiqu
    Lu, Jun
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (01) : 65 - 73
  • [5] FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Juan Du
    Lin Li
    Zhouluo Ou
    Chenfei Kong
    Yu Zhang
    Zhixiong Dong
    Shan Zhu
    Hao Jiang
    Zhimin Shao
    Baiqu Huang
    Jun Lu
    Breast Cancer Research and Treatment, 2012, 131 : 65 - 73
  • [6] FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
    Yang, Zhi
    Jiang, Shuai
    Cheng, Yicheng
    Li, Tian
    Hu, Wei
    Ma, Zhiqiang
    Chen, Fulin
    Yang, Yang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (12) : 797 - 816
  • [7] Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Juan Du
    Lin Li
    Zhouluo Ou
    Chenfei Kong
    Yu Zhang
    Zhixiong Dong
    Shan Zhu
    Hao Jiang
    Zhimin Shao
    Baiqu Huang
    Jun Lu
    Breast Cancer Research and Treatment, 2016, 156 : 609 - 610
  • [8] The Diverse Consequences of FOXC1 Deregulation in Cancer
    Gilding, L. Niall
    Somervaille, Tim C. P.
    CANCERS, 2019, 11 (02):
  • [9] FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer
    Wang, Jinhua
    Ray, Partha
    Qu, Ying
    Sim, Myung-Shin
    Shamonki, Jaime
    Bagaria, Sanjay
    Ye, Xing
    Liu, Bingya
    Walter, Michael
    Hoon, Dave
    Giuliano, Armando
    Cui, Xiaojiang
    CANCER RESEARCH, 2010, 70
  • [10] Carotenoid Nanovector for Efficient Therapeutic Gene Knockdown of Transcription Factor FOXC1 in Liver Cancer
    Misra, Santosh K.
    Ray, Tania
    Ostadhossein, Fatemeh
    Kim, Bomy
    Ray, Partha S.
    Pan, Dipanjan
    BIOCONJUGATE CHEMISTRY, 2016, 27 (03) : 594 - 603